MKI67 and glioblastoma: We found that cell proliferation was markedly reduced in the GBM xenografts derived from GSCs expressing shSATB2 than control tumors as demonstrated by Ki67 immunofluorescence (Fig 3F and G; Appendix Fig S3I and J).